An Efficacy and Safety Study of JNJ-64041757, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Nivolumab Versus Nivolumab Monotherapy in Participants With Advanced Adenocarcinoma of the Lung
Condition:   Adenocarcinoma of Lung Interventions:   Biological: JNJ-64041757;   Drug: Nivolumab Sponsor:   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2017 Category: Research Source Type: clinical trials

Successful Treatment of Maternal Listeria Monocytogenes Bacteremia in the First Trimester
Condition:   Listeria Monocytogenes Intervention:   Drug: Ampicillin Injection Sponsor:   Far Eastern Memorial Hospital Recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2017 Category: Research Source Type: clinical trials

Neoadjuvant Listeria or Daratumumab in Prostate Cancer
Conditions:   Malignant Neoplasms of Male Genital Organs;   Prostate Cancer Intervention:   Drug: Daratumumab Sponsors:   M.D. Anderson Cancer Center;   Janssen-Cilag div. of Johnson&Johnson  SE Not yet recruiting - verified January 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2017 Category: Research Source Type: clinical trials

Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis
Conditions:   Colon Cancer;   Colitis Intervention:   Sponsor:   The University of Texas Health Science Center at San Antonio Not yet recruiting - verified January 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2016 Category: Research Source Type: clinical trials